Effamall Insights More
      China’s Vitamin Market Consolidates Narrowly, with VA and VE Prices Firming Amid Downstream Caution
      China’s Vitamin Market Consolidates Narrowly, with VA and VE Prices Firming Amid Downstream Caution
      Vitamin 08-28 17:36
      Dicalcium Phosphate Market Continues to Weaken; Sodium Bicarbonate Holds Steady; Whey Powder Prices Strengthen
      Dicalcium Phosphate Market Continues to Weaken; Sodium Bicarbonate Holds Steady; Whey Powder Prices Strengthen
      Minerals 08-28 17:05
      China’s Amino Acid Market: Methionine Prices Continue to Edge Lower and Other Varieties Hold Steady Amid Negotiated Deals; European Lysine Prices Rise Notably
      China’s Amino Acid Market: Methionine Prices Continue to Edge Lower and Other Varieties Hold Steady Amid Negotiated Deals; European Lysine Prices Rise Notably
      Amino Acid 08-28 17:02
      Zhejiang Medicine Reports H1 2026 Net Profits of RMB 606 Million, Down 9.99% Year-on-Year
      Zhejiang Medicine Reports H1 2026 Net Profits of RMB 606 Million, Down 9.99% Year-on-Year
      Enterprise News 08-28 11:44
      Hengtong Holding Reports H1 2026 Net Profits of RMB 91.62 Million, Down 27.83% YoY
      Hengtong Holding Reports H1 2026 Net Profits of RMB 91.62 Million, Down 27.83% YoY
      Enterprise News 08-28 11:42
      Star Lake Bioscience Reports H1 2026 Net Profits of RMB 70.72 Million, Down 91.54% YoY
      Star Lake Bioscience Reports H1 2026 Net Profits of RMB 70.72 Million, Down 91.54% YoY
      Enterprise News 08-28 11:41
      NengTer Technology Records H1 2026 Net Profits of RMB 93.84 Million
      NengTer Technology Records H1 2026 Net Profits of RMB 93.84 Million
      Enterprise News 08-28 11:40
      Kingdomway Group Reports H1 2026 Net Profits of RMB 170 Million, Down 31.23% YoY
      Kingdomway Group Reports H1 2026 Net Profits of RMB 170 Million, Down 31.23% YoY
      Enterprise News 08-28 11:39
      Huaheng Biotechnology: H1 2026 Net Profits Drop 12.22% YoY to RMB 100 Million
      Huaheng Biotechnology: H1 2026 Net Profits Drop 12.22% YoY to RMB 100 Million
      Enterprise News 08-28 11:37
      North China Pharmaceutical Posts H1 2026 Net Profits of RMB 63.85 Million, Down 48.30% YoY
      North China Pharmaceutical Posts H1 2026 Net Profits of RMB 63.85 Million, Down 48.30% YoY
      Enterprise News 08-28 11:36
        All Type
        Loading...
        Loading...